← Leaderboards
Penelope A Morel
University Of Pittsburgh At Pittsburgh
$5,799,510
Attributed
$5,799,510
Total exposure
11
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $388.4K · FY2010–22$500K$375K$250K$125K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$6,192,267 · 12
By mechanism
R01$3,185,232 · 3
T32$1,729,039 · 1
S10$785,514 · 6
R21$295,378 · 1
P01$197,104 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Pittsburgh At Pittsburgh
Same institution · by research overlap
- Albert D Donnenberg$4,266,402
- Joel S Greenberger$22,565,586
- Timothy B Oriss$3,672,680
- Pat R Levitt$42,762,313
- Alison Morris$31,399,077
Others in their field
Top investigators on “Autoimmunity”
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$303,553,812
- Barton F Haynes · Duke University$175,178,961
- Jeffrey P Krischer · University Of South Florida$145,926,425
- Jane Hoyt Buckner · Benaroya Research Inst At Virginia Mason$84,342,024
- Mark S Anderson · University Of California, San Francisco$69,470,335
- Robert S Negrin · Stanford University$48,464,292
Research focus
AutoimmunityProtein IsoformsLeukocyte Activation /TransformationTissue /Cell CultureCytokineLaboratory MouseInsulin Dependent Diabetes MellitusEffector CellAntibodiesElementsBaseBiological Signal TransductionDif FactorCancer ImmunotherapyCellsCell Mediated CytotoxicityDoseCell GrowthAntibody ReceptorCell PhysiologyAkt InhibitionAlternative SplicingCell SurvivalCd Antigens
Grant awards (27)
Akt controls alternative splicing in T helper call fate decisions$388,425
R01 · FY2022 · AI · contact PI
Akt controls alternative splicing in T helper call fate decisions$388,425
R01 · FY2021 · AI · contact PI
Akt controls alternative splicing in T helper call fate decisions$388,425
R01 · FY2020 · AI · contact PI
Akt controls alternative splicing in T helper call fate decisions$388,425
R01 · FY2019 · AI · contact PI
Akt controls alternative splicing in T helper call fate decisions$386,996
R01 · FY2018 · AI · contact PI
Autoimmunity and Immunopathology Training Program$300,392
T32 · FY2014 · AI · contact PI
Autoimmunity and Immunopathology Training Program$367,711
T32 · FY2013 · AI · contact PI
Autoimmunity and Immunopathology Training Program$340,777
T32 · FY2012 · AI · contact PI
Autoimmunity and Immunopathology Training Program$364,324
T32 · FY2011 · AI · contact PI
Autoimmunity and Immunopathology Training Program$355,835
T32 · FY2010 · AI · contact PI
BD FACSARIA FLOW CYTOMETER 3 LSR$392,757
S10 · FY2004 · RR
BD FACSARIA FLOW CYTOMETER: CANCER, LYMPHOMA, MYELOMA$90,825
S10 · FY2004 · RR
BD FACSARIA FLOW CYTOMETER: INFECTIOUS DIS: TB, LUNG, CHAGAS, HSV KERATITIS, PNE$90,825
S10 · FY2004 · RR
BD FACSARIA FLOW CYTOMETER: LIVER DISEASES, TRANSPLANTATION$90,825
S10 · FY2004 · RR
BD FACSARIA FLOW CYTOMETER: AUTOIMMUNE DIS &GENETICS: DIABETES, RHEUMATOID ARTH$90,825
S10 · FY2004 · RR
BD FACSARIA FLOW CYTOMETER: NON-HUMAN PRIMATE MODEL OF TUBERCULOSIS AND AIDS$29,457
S10 · FY2004 · RR
NOVEL CD32 ISOFORMS MODULATE NK CELL FUNCTIONS$180,096
R01 · FY2003 · AI
NOVEL CD32 ISOFORMS MODULATE NK CELL FUNCTIONS$155,558
R01 · FY2002 · AI
DNA Immunizations with GAD65 to Induce Tolerance$147,420
R21 · FY2002 · DK
DENDRITIC CELL MEDIATED THERAPY OF AUTOIMMUNE DIABETES$0
P01 · FY2002 · CA
MATHEMATICAL MODELING OF IMMUNOLOGICAL REACTIONS$289,634
R01 · FY2001 · AI
NOVEL CD32 ISOFORMS MODULATE NK CELL FUNCTIONS$172,790
R01 · FY2001 · AI
DNA Immunizations with GAD65 to Induce Tolerance$147,958
R21 · FY2001 · DK
DENDRITIC CELL MEDIATED THERAPY OF AUTOIMMUNE DIABETES$0
P01 · FY2001 · CA
MATHEMATICAL MODELING OF IMMUNOLOGICAL REACTIONS$281,199
R01 · FY2000 · AI
DENDRITIC CELL MEDIATED THERAPY OF AUTOIMMUNE DIABETES$197,104
P01 · FY2000 · CA
NOVEL CD32 ISOFORMS MODULATE NK CELL FUNCTIONS$165,259
R01 · FY2000 · AI